Comparing drug-coated balloons and drug-eluting stents for coronary artery disease
Official title: DRUG RELEASING BALL vs. PHARMACOACTIVE STENT IN LARGE VESSELS: MORPHOLOGICAL ANALYSIS AND FUNCTION VASOMOTOR (DEBORA STUDY)
Run by Fundación EPIC · NCT06448637 · Data updated 2026-11-12
This study is testing whether a special balloon or a stent works better to improve blood flow in people with coronary artery disease after eight months.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 94 (estimated) |
| Sponsor | Fundación EPIC Academic / other |
| Drugs / interventions | methotrexate |
| Locations | 9 sites (Barcelona and 8 other locations) |
| Status | Recruiting |
| Started | October 23, 2024 |
| Main results expected | December 1, 2026 |
| Study ends | December 1, 2027 |
| Registry record updated | September 30, 2026 |
| Trial ID | NCT06448637 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults aged 18 and older with chronic or acute coronary syndrome and de novo lesions in large coronary vessels.
✕Probably not a fit
Patients with contraindications to acetylcholine or nitroglycerin, or those with a history of coronary vasospasm, may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study is a randomized, controlled, open-label, multicenter trial that evaluates the vasomotor function of patients with coronary artery disease eight months after treatment with either a drug-coated balloon (DCB) or a drug-eluting stent (DES) in large vessels measuring 3.5 mm or more. The study aims to determine the effectiveness of these two interventions in improving vascular function. Participants will be monitored for their response to treatment and any potential complications. The findings will contribute to understanding the best treatment options for patients with coronary artery disease.
Why it matters
Potential benefit: If successful, this study could provide insights into more effective treatment options for patients with coronary artery disease, potentially improving their vascular health.
How similar studies have gone: Previous studies have shown varying success with drug-coated balloons and drug-eluting stents, but this specific comparative approach is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Patients who meet all of the following conditions are included. * Patients aged ≥ 18 years and; * Patients with chronic coronary syndrome, acute coronary syndrome without ST segment elevation or acute coronary syndrome with elevation ST segment in non-culprit lesions 48 hours after the event and; * Patients with de novo lesions in vessels ≥ 3.5 mm without calcification significant no visible thrombus and; * Patients who have been informed of the characteristics of the study and have provided their written informed consent. Exclusion Criteria: Patients who meet at least one of the following conditions are excluded: * Patients with any contraindication for the administration of acetylcholine (ACh) or nitroglycerin (NTG). * Patients with a history of coronary vasospasm or spontaneous dissection of the coronary artery. * Patients with significant medical, surgical or psychiatric condition that would affect the safety of the subject or influence the outcome of the study according to the doctor's opinion. * Patients who received a combination of DES and DCB in the same vessel * Patients with glomerular filtration rate \<30 ml/min/ 1.73 m2 * Patients with body mass index \>35 (may affect the evaluation qualitative diameter of the coronary artery). * Patients with symptomatic congestive heart failure. * Patients with significant autoimmune inflammatory conditions and patients taking immunomodulatory medications (including methotrexate, cyclosporine, steroids). * Patients with heart transplant. * Patients with anemia (Hb \<12 g/dL in men and \<10 g/dL in women). * Patients, women of childbearing age with a positive pregnancy test. * Pregnant female patients. * Patients included in other clinical trials with active follow-up.
Where it's running
-
Hospital Universitari Vall d'Hebron
Barcelona, Spain Recruiting -
Hospital Universitario de Cabueñes
Gijón, Spain Recruiting -
Hospital Universitario Juan Ramón Jiménez
Huelva, Spain Recruiting -
Hospital Universitario de Leon
León, Spain Recruiting -
Hospital Universitario Lucus Augusti
Lugo, Spain Recruiting -
Hospital de Merida
Mérida, Spain Recruiting
Show 3 more locations
-
Hospital Universitario Central de Asturias
Oviedo, Spain Recruiting -
Hospital Provincial de Pontevedra
Pontevedra, Spain Recruiting -
Hospital Universitari de Tarragona Joan XXIII
Tarragona, Spain Recruiting
Study contacts
- Study coordinator: IÑIGO LOZANO MARTINEZ-LUENGAS, MD, PhD
- Email: inigo.lozano@fundacionepic.org
- Phone: 0034630901145
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
μFR-guided Drug-Coated Balloon Angioplasty vs Angiography-guided Angioplasty in Coronary Artery Disease
This trial tests whether using computational μFR guidance during drug-coated balloon angioplasty is better than standard angiography guidance for people with de novo coronary artery lesions.
-
Gastric Ultrasound Before CABG to See if Heart Function Changes Stomach Contents
This study checks whether people with weaker heart function before elective CABG have different stomach contents seen on ultrasound.
-
Can preoperative photon-counting CT help predict heart recovery after bypass surgery?
This observational study tests whether a preoperative photon-counting CT can help predict heart function 3 months after coronary bypass surgery in adults with coronary artery disease.
-
Real-World Drug-Coated Balloon Angioplasty in Coronary Artery Disease
This registry tests how drug-coated balloons perform in everyday clinical practice for adults with coronary artery disease undergoing PCI.
-
Predicting vasopressor needs after anesthesia in elective on-pump CABG using dynamic arterial elastance
This study tests whether EaDyn measured after induction can help predict which patients will need vasopressors during elective on-pump CABG.
-
Intraoperative Pulse Pressure Variation and Postoperative Lactate Clearance in CABG Patients
This study tests whether the amount a patient’s pulse pressure varies during surgery relates to how quickly lactate levels drop after CABG.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.